4 Results for "

SCY078

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "SCY078" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-107126
CAS No.: 1207753-03-4
Purity:  99.83%
Synonyms: MK 3118; SCY-078
Target:  

Fungal

Research Areas:  

Infection

Ibrexafungerp (MK 3118) is an orally active β-1,3-glucan synthesis inhibitor, with potential antifungal activity. Ibrexafungerp can be used for research of Candida and Aspergillus infections .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107126A
CAS No.: 1965291-08-0
Purity:  99.38%
Synonyms: MK 3118 citrate; SCY-078 citrate
Target:  

Fungal

Research Areas:  

Infection

Ibrexafungerp citrate (MK 3118 citrate) is an orally active β-1,3-glucan synthesis inhibitor, with potential antifungal activity. Ibrexafungerp citrate is an investigational agent for the treatment of Candida and Aspergillus infections .
loading...
    loading...
Cat. No.: HY-107126B
CAS No.: 1965291-14-8
Synonyms: MK 3118 phosphate; SCY-078 phosphate
Target:  

Fungal

Research Areas:  

Infection

Ibrexafungerp phosphate is an orally active β-1,3-glucan synthesis inhibitor, with potential antifungal activity. Ibrexafungerp phosphate can be used for research of Candida and Aspergillus infections .
loading...
    loading...
Cat. No.: HY-107126AR
CAS No.: 1965291-08-0
Synonyms: MK 3118 citrate (Standard); SCY-078 citrate (Standard)
Research Areas:  

Infection

Ibrexafungerp citrate (Standard) (MK 3118 citrate (Standard)) is the analytical standard of Ibrexafungerp (citrate) (HY-107126A). This product is intended for research and analytical applications. Ibrexafungerp citrate (MK 3118 citrate) is an orally active β-1,3-glucan synthesis inhibitor, with potential antifungal activity. Ibrexafungerp citrate is an investigational agent for the treatment of Candida and Aspergillus infections .
loading...
    loading...